Improving psychostimulant adherence in children with ADHD

References

• Johnston C, Seipp C, Hommersen P, Hoza B, Fine S. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents’ beliefs and attributions. Child Care Health Dev.31(6), 669–677 (2005).
   PubMed Web of Science ®Google Scholar
• Dosreis S, Zito JM, Safer DJ, Soeken KL, Mitchell JW Jr, Ellwood LC. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J. Dev. Behav. Pediatr.24(3), 155–162 (2003).
   PubMed Web of Science ®Google Scholar
• Gau SS, Chen SJ, Chou WJ et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J. Clin. Psychiatry69(1), 131–140 (2008).
   PubMed Web of Science ®Google Scholar
• The MTA Cooperative Group, National Institute of Mental Health multimodal treatment study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics113(4), 762–769 (2004).
   PubMed Web of Science ®Google Scholar
• Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J. Am. Acad. Child Adolesc. Psychiatry43(5), 559–567 (2004).
   PubMed Web of Science ®Google Scholar
• Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J. Dev. Behav. Pediatr.27(1), 1–10 (2006).
   PubMed Web of Science ®Google Scholar
• Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J. Am. Acad. Child Adolesc. Psychiatry39(8), 975–994 (2000).
   PubMed Web of Science ®Google Scholar
• dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R. Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community. J. Behav. Health Serv. Res.33(4), 423–430 (2006).
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Spencer T, Wilens TE, Macpherson HA, Faraone SV. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am. J. Psychiatry165(5), 597–603 (2008).
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Truong NL et al. Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am. J. Psychiatry165(5), 604–609 (2008).
   PubMed Web of Science ®Google Scholar
• Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: friends or foes? Harv. Rev. Psychiatry9(5), 223–233 (2001).
   PubMed Web of Science ®Google Scholar
• Hansen DL, Hansen EH. Caught in a balancing act: parents’ dilemmas regarding their ADHD child’s treatment with stimulant medication. Qual. Health Res.16(9), 1267–1285 (2006).
   PubMed Web of Science ®Google Scholar
• Singh I. Will the “real boy” please behave: dosing dilemmas for parents of boys with ADHD. Am. J. Bioeth.5(3), 34–47 (2005).
   PubMed Web of Science ®Google Scholar
• Perwien A, Hall J, Swensen A, Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. [see comment]. J. Manag. Care Pharm.10(2), 122–129 (2004).
   PubMedGoogle Scholar
• Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch. Pediatr. Adolesc. Med.159(6), 572–578 (2005). Erratum appears in Arch. Pediatr. Adolesc. Med.159(9), 875 (2005).
   PubMed Web of Science ®Google Scholar
• Miller AR, Lalonde CE, McGrail KM. Children’s persistence with methylphenidate therapy: a population-based study. Can. J. Psychiatry49(11), (2004).
   Google Scholar
• Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1‑year, open-label study of OROS methylphenidate in children with ADHD. J. Atten. Disord.11(2), 157–166 (2007).
   PubMedGoogle Scholar
• Vitiello B, Severe JB, Greenhill LL et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J. Am. Acad. Child Adolesc. Psychiatry40(2), 188–196 (2001).
   PubMed Web of Science ®Google Scholar
• Wilens T, Pelham W, Stein M et al. ADHD treatment with once-daily OROS methylphenidate: interim 12‑month results from long-term open label study. J. Am. Acad. Child Adolesc. Psychiatry42, 424–433 (2003).
   PubMed Web of Science ®Google Scholar
• Gau SS, Shen HY, Chou MC, Tang CS, Chiu YN, Gau CS. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J. Child Adolesc. Psychopharmacol.16(3), 286–297 (2006).
   PubMed Web of Science ®Google Scholar
• Schachar R, Jadad AR, Gauld M et al. Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies. Can. J. Psychiatry47(4), 337–348 (2002).
   PubMed Web of Science ®Google Scholar
• Swanson JM, Hinshaw SP, Arnold LE et al. Secondary evaluations of the MTA 36-month outcomes: propensity score and growth mixture model analyses. J. Am. Acad. Child Adolesc. Psychiatry46(8), 1003–1014 (2007).
   PubMed Web of Science ®Google Scholar
• Rieppi R, Greenhill LL, Ford RE et al. Socioeconomic status as a moderator of ADHD treatment outcomes. J. Am. Acad. Child Adolesc. Psychiatry41(3), 269–277 (2002).
   PubMed Web of Science ®Google Scholar
• Leslie LK, Plemmons D, Monn AR, Palinkas LA. Investigating ADHD treatment trajectories: listening to families’ stories about medication use. J. Dev. Behav. Pediatr.28(3), 179–188 (2007).
   PubMed Web of Science ®Google Scholar
• Jensen PS, Arnold LE, Swanson JM et al. 3-year follow-up of the NIMH MTA study. J. Am. Acad. Child Adolesc. Psychiatry46(8), 989–1002 (2007).
   PubMed Web of Science ®Google Scholar
• Singh I. Boys will be boys: fathers’ perspectives on ADHD symptoms, diagnosis, and drug treatment. Harv. Rev. Psychiatry11(6), 308–316 (2003).
   PubMed Web of Science ®Google Scholar
• Meaux JB, Hester C, Smith B, Shoptaw A. Stimulant medications: a trade-off? The lived experience of adolescents with ADHD. J. Spec. Pediatr. Nurs.11(4), 214–226 (2006).
   PubMed Web of Science ®Google Scholar
• Charach A, Skyba A, Cook L, Antle BJ. Using stimulant medication for children with ADHD: what do parents say? A brief report. J. Can. Acad. Child Adolesc. Psychiatry15(2), 75–83 (2006).
   PubMedGoogle Scholar
• Bussing R, Gary FA, Mills TL, Garvan CW. Parental explanatory models of ADHD: gender and cultural variations. Soc. Psychiatry Psychiatr. Epidemiol.38(10), 563–575 (2003).
   PubMed Web of Science ®Google Scholar
• Bussing R, Koro-Ljungberg ME, Gary F, Mason DM, Garvan CW. Exploring help-seeking for ADHD symptoms: a mixed-methods approach. Harv. Rev. Psychiatry13(2), 85–101 (2005).
   PubMed Web of Science ®Google Scholar
• Corkum P, Rimer P, Schachar R. Parental knowledge of attention-deficit hyperactivity disorder and opinions of treatment options: impact on enrollment and adherence to a 12-month treatment trial. Can. J. Psychiatry44(10), 1043–1048 (1999).
   PubMed Web of Science ®Google Scholar
• Johnston C, Hommersen P, Seipp C. Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics. Behav. Ther.39, 22–32 (2008).
   PubMed Web of Science ®Google Scholar
• Bull C, Whelan T. Parental schemata in the management of children with attention deficit-hyperactivity disorder. Qual. Health Res.16(5), 664–678 (2006).
   PubMed Web of Science ®Google Scholar
• Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J. Am. Acad. Child Adolesc. Psychiatry36(6), 754–763 (1997).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Lopez M, Crismon ML et al. A feasibility study of the children’s medication algorithm project (CMAP) algorithm for the treatment of ADHD. J. Am. Acad. Child Adolesc. Psychiatry42(3), 279–287 (2003).
   PubMed Web of Science ®Google Scholar
• Cheng J, Walter EC. Nonadherence in Pediatrics in Patient Treatment Adherence Concepts, Interventions, and Measurement. Bosworth HB, Oddone EZ, Weinberger M (Eds). Lawrence Erlbaum Associates, Inc., Mahwah, NJ, USA, 239–273 (2006).
   Google Scholar
• Creswell J. Qualitative Inquiry and Research Design. Sage Publications, CA, USA (1998).
   Google Scholar
• Swanson JM, Elliott GR, Greenhill LL et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J. Am. Acad. Child Adolesc. Psychiatry46(8), 1015–1027 (2007).
   PubMed Web of Science ®Google Scholar
• Frey M, Naar-King S. Measurement corner. The challenge of measuring adherence in children and adolescents. J. Child Fam. Nurs.4(4), 296–300 (2001).
   Google Scholar
• Charach A, Gajaria A, Skyba A, Chen S. Documenting adherence to psychostimulants in children with ADHD. J. Can. Acad. Child Adolesc. Psychiatry17(3), 131–136 (2008).
   PubMedGoogle Scholar
• Becker M, Maiman L. Sociobehavioral determinants of compliance with health and medical care recommendations. Med. Care13, 10–24 (1975).
   PubMed Web of Science ®Google Scholar
• Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Prentice Hall, NJ, USA (1980).
   Google Scholar
• Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am. Psychol.47, 1102–1114 (1992).
   PubMed Web of Science ®Google Scholar
• Pescosolido BA. Beyond rational choice: the social dynamics of how people seek help. Am. J. Sociol.97, 1096–1138 (1992).
   Web of Science ®Google Scholar
• Charach A, Volpe T, Boydell KM, Gearing RE. A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv. Rev. Psychiatry16(2), 126–135 (2008).
   PubMed Web of Science ®Google Scholar
• Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics114(5), e541–e547 (2004).
   PubMed Web of Science ®Google Scholar
• Reach G. Role of habit in adherence to medical treatment. Diabet. Med.22, 415–420 (2005).
   PubMed Web of Science ®Google Scholar
• Greenhill LL, Pliszka S, Dulcan MK et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry41(Suppl. 2), 26S–49S (2002).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics108(4), 1033–1044 (2001).
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Wibbelsman CJ, Brown TE. Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics115(6), 1734–1746 (2005).
   PubMed Web of Science ®Google Scholar
• Harris RP, Helfand M, Woolf SH et al. Current methods of the U.S. Preventative Services Task Force: a review of the process. Am. J. Prev. Med.20(Suppl. 3), 21–35 (2001).
   PubMed Web of Science ®Google Scholar
• Guion LA. Triangulation: Establishing the Validity of Qualitative Studies. Institute of Food and Agricultural Sciences, Gainsville, Florida, University of Florida, FL, USA (2002).
   Google Scholar
• Law M, Stewart D, Letts L, Pollock N, Bosch J, Westmorland M. Critical Review Form – Qualitative Studies. McMaster University, Hamilton, ON, Canada (1998).
   Google Scholar